FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC
FDA Approves Perioperative Pembrolizumab-EV Regimen for MIBC Oncology Nursing News
Regulatory Approvals
FDA approves new ADHD medication: 5 things to know
FDA approves new ADHD medication: 5 things to know Becker's Behavioral Health
FDA Approves Blood-Based Test for Colorectal Cancer Screening
FDA Approves Blood-Based Test for Colorectal Cancer Screening CancerNetwork
FDA Approves First NDSRI for ADHD in Adults and Children
FDA Approves First NDSRI for ADHD in Adults and Children Medscape
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric…